The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.16
Bid: 52.16
Ask: 52.20
Change: -0.14 (-0.27%)
Spread: 0.04 (0.077%)
Open: 52.68
High: 52.82
Low: 52.14
Prev. Close: 52.30
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

USD Notes Tender Offer Results

4 Nov 2016 11:06

RNS Number : 3744O
Lloyds Banking Group PLC
04 November 2016
 

 

 

 

 

 

 

 

4 November 2016

Lloyds Bank plc - RESULTS OF ANY AND ALL TENDER OFFER

Lloyds Bank plc ("Lloyds Bank" or the "Offeror") is today announcing the final results of its previously announced cash tender offer for any and all of certain series of outstanding U.S. dollar denominated notes (the "Any and All Notes") issued by Lloyds Bank plc and guaranteed by Lloyds Banking Group plc (the "Any and All Tender Offer"). The Any and All Tender Offer was made on the terms and subject to the conditions set out in the Offer to Purchase dated 27 October 2016 (the "Offer to Purchase") and the related notice of guaranteed delivery.

 

Capitalised terms not otherwise defined in this announcement have the same meaning as in the Offer to Purchase.

 

Based on information provided by the Tender Agent, $3,296,365,000 in aggregate principal amount of the Any and All Notes listed in the table below were validly tendered and not validly withdrawn by 5:00 p.m., New York City time, on 3 November 2016 (the "Any and All Expiration Deadline"), as more fully set forth below. The Offeror has accepted all Any and All Notes that were validly tendered and not validly withdrawn prior to the Any and All Expiration Deadline. The Any and All Settlement Date is expected to be 8 November 2016. In addition, $18,907,000 in aggregate principal amount of the Any and All Notes were tendered using the guaranteed delivery procedures.

 

The table below sets forth, among other things, the principal amount of each series of Any and All Notes validly tendered and not validly withdrawn at or prior to the Any and All Expiration Deadline:

 

Any and All Notes

ISIN/CUSIP

Principal Amount Outstanding

 

Aggregate Principal Amount Tendered(1)

Aggregate Principal Amount Tendered Using Guaranteed Delivery Procedures

Any and All Consideration(2)

1.750% Senior Notes due 2018 (Series 1)

US53944VAC37

53944VAC3

$1,000,000,000

$682,820,000

$2,825,000

$1,004.38

1.750% Senior Notes due 2018 (Series 2)

US53944VAG41

53944VAG4

$1,250,000,000

$812,018,000

$320,000

$1,004.90

2.350% Senior Notes due 2019 (Series 3)

US53944VAB53

53944VAB5

$1,000,000,000

$533,848,000

N/A

$1,018.82

2.400% Senior Notes due 2020 (Series 4)

US53944VAE92

53944VAE9

$1,000,000,000

$532,901,000

$200,000

$1,020.21

3.500% Senior Notes due 2025 (Series 5)

US53944VAH24

53944VAH2

$1,250,000,000

$734,778,000

$15,562,000

$1,067.41

 

(1) Excluding principal amounts of Any and All Notes tendered using guaranteed delivery procedures.

(2) Per $1,000 in principal amount of Any and All Notes accepted for purchase.

 

FURTHER INFORMATION

 

Lucid Issuer Services Limited acted as tender agent for the Any and All Tender Offer. Lloyds Bank plc acted as Global Co-Ordinator and Joint Dealer Manager, and BNP Paribas Securities Corp., Deutsche Bank Securities Inc. and UBS Limited acted as Joint Dealer Managers for the Any and All Tender Offer. Questions regarding the Any and All Tender Offer should be directed to Lloyds Bank plc at +1 (855) 400-6511 (U.S. Toll-Free), +1 (212) 827-3105 (U.S. Collect) or +44 (0) 20 7158 2720 (Europe); BNP Paribas Securities Corp. at +1 (888) 210-4358 (U.S. Toll-Free), +1 (212) 841-3059 (U.S. Collect) or +44 (0) 20 7595 8668 (Europe); Deutsche Bank Securities at +1 (866) 627-0391 (U.S. Toll-Free), +1 (212) 250-2955 (U.S. Collect) or +44 (0) 20 7545 8011 and UBS Limited at +1 (888) 719-4210 (U.S. Toll-Free), +1 (203) 719-4210 (U.S. Collect) or +44 (0) 20 7568 2133 (Europe).

 

Concurrent Non-U.S. Offer

 

On 27 October 2016, the Offeror also launched an exchange offer (the "Non-U.S. Offer") in respect of certain of Lloyds Bank's outstanding euro-denominated debt securities. This announcement does not relate to the Non-U.S. Offer.

 

Investor Relations

Andrew Downey Email: andrew.downey@finance.lloydsbanking.com

Director, Investor Relations Telephone: +44 (0) 20 7356 2334

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBIBMTMBAMBLF
Date   Source Headline
6th May 20225:43 pmRNSTransaction in Own Shares
5th May 20225:16 pmRNSTransaction in Own Shares
4th May 20225:16 pmRNSTransaction in Own Shares
3rd May 20225:22 pmRNSTransaction in Own Shares
29th Apr 20226:08 pmRNSTotal Voting Rights
29th Apr 20225:19 pmRNSTransaction in Own Shares
28th Apr 20225:41 pmRNSTransaction in Own Shares
27th Apr 20225:25 pmRNSTransaction in Own Shares
27th Apr 20223:42 pmRNSPublication of Supplementary Prospectus
27th Apr 20221:02 pmRNS2022 Q1 Interim Management Statement
27th Apr 20227:00 amRNS2022 Q1 Interim Management Statement
26th Apr 20225:31 pmRNSTransaction in Own Shares
25th Apr 20225:15 pmRNSTransaction in Own Shares
22nd Apr 20225:22 pmRNSTransaction in Own Shares
20th Apr 20225:13 pmRNSTransaction in Own Shares
19th Apr 20225:06 pmRNSTransaction in Own Shares
14th Apr 20225:23 pmRNSTransaction in Own Shares
13th Apr 20225:21 pmRNSTransaction in Own Shares
12th Apr 20225:09 pmRNSTransaction in Own Shares
12th Apr 20222:00 pmRNSDirector/PDMR Shareholding
11th Apr 20225:26 pmRNSTransaction in Own Shares
8th Apr 20226:32 pmRNSTransaction in Own Shares
7th Apr 20225:20 pmRNSTransaction in Own Shares
6th Apr 20225:32 pmRNSTransaction in Own Shares
5th Apr 20225:34 pmRNSTransaction in Own Shares
4th Apr 20225:36 pmRNSTransaction in Own Shares
1st Apr 20225:37 pmRNSTotal Voting Rights Replacement
1st Apr 20225:33 pmRNSTransaction in Own Shares
1st Apr 20222:00 pmRNSTotal Voting Rights
31st Mar 20226:22 pmRNSTransaction in Own Shares
31st Mar 20223:44 pmRNSAT1 Repurchase Offer Results
30th Mar 20225:40 pmRNSTransaction in Own Shares
29th Mar 20225:30 pmRNSTransaction in Own Shares
28th Mar 20225:38 pmRNSTransaction in Own Shares
28th Mar 20224:24 pmRNSTotal Voting Rights
25th Mar 20225:38 pmRNSTransaction in Own Shares
24th Mar 20225:41 pmRNSTransaction in Own Shares
24th Mar 20222:14 pmRNS2021 Annual Report and Accounts
24th Mar 20221:31 pmRNSDirector/PDMR Shareholding
23rd Mar 20226:08 pmRNSNotice of Annual General Meeting
23rd Mar 20225:29 pmRNSTransaction in Own Shares
23rd Mar 20228:59 amRNSAT1 Repurchase Offer
22nd Mar 20225:27 pmRNSTransaction in Own Shares
21st Mar 20225:47 pmRNSTransaction in Own Shares
18th Mar 20225:30 pmRNSTransaction in Own Shares
17th Mar 20226:19 pmRNSTransaction in Own Shares
16th Mar 20225:32 pmRNSTransaction in Own Shares
15th Mar 20225:52 pmRNSTransaction in Own Shares
11th Mar 20225:45 pmRNSTransaction in Own Shares
10th Mar 20225:10 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.